Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
AB Science
company
About
AB Science is a pharmaceutical company specializing in drugs use tyrosine kinase inhibitors.
- 101 - 250
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- €6M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 101 - 250
- Operating Status
- Active
AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. They are innovators and scientific entrepreneurs in the field of life science.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€6M
AB Science has raised a total of
€6M
in funding over 2 rounds. Their latest funding was raised on
Dec 22, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 22, 2022 | Post-IPO Debt | €6M | 1 |
European Investment Bank
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
AB Science is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
